Rabavert Kit
Product Images NDC 50632-010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Rabavert (NDC 50632-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bavarian Nordic A/s, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diagram Of Vial (Rabavert Spl Graphic 01)

Diagram Of Vial (Rabavert Spl Graphic 01)
The text describes a syringe with a white cap, a textured syringe tip, and a holding ring.*
FDA Label Image

Step 1.jpg (Rabavert Spl Graphic 02)

FDA Label Image

Step 2 (Rabavert Spl Graphic 03)

FDA Label Image

Step3.jpg (Rabavert Spl Graphic 04)

FDA Label Image

Needle Step 1.jpg (Rabavert Spl Graphic 05)

FDA Label Image

Needle Step 2.jpg (Rabavert Spl Graphic 06)

FDA Label Image

Principal Display Panel (Carton Label)

Principal Display Panel (Carton Label)
RABAVERT is a rabies vaccine indicated for both pre- and post-exposure intramuscular immunization in all age groups. The vaccine comes in a single-dose freeze-dried form and contains no preservatives. The potency of 1 dose of the vaccine is at least 2.5 I.U of rabies antigen. Rabies virus is propagated in Chick Embryo Cells and inactivated with B-propioactone. The vaccine contains a disposable pre-filled syringe of Sterile Diluent for reconstitution of RABAVERT. Longer needles for reconstitution and smaller needles for injection are provided. Instructions for use are enclosed, and the vaccine should be stored at 2°C to 8°C (36°F to 46°F). RABAVERT is manufactured for Bavarian Nordic A/S and distributed by Bavarian Nordic Inc.*
FDA Label Image

Principal Display Panel (Vial Label)

Principal Display Panel (Vial Label)
This is a description of RABAVERT, a rabies vaccine. It comes in a single-dose vial with a potency of over 2.5 IU/mL. The vaccine is manufactured for Bavarian Nordic A/S by GSK Vaccines GmbH. The lot number and expiration date are also provided.*
FDA Label Image

Principal Display Panel (Diluent Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.